Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

3,739 studies for “rheumatoid arthritis”

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Recruiting
NCT07137598Phase 2Updated Jul 27, 2026
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
United States, Argentina, Belgium, Brazil, Denmark +6 more
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid ArthritisCompleted
NCT03025308Phase 3Updated Jul 27, 2026
Sponsor: Alfasigma S.p.A.
Rheumatoid Arthritis
United States, Argentina, Australia, Belgium, Bulgaria +27 more
Disulfiram in Rheumatoid ArthritisNot Yet Recruiting
NCT07534332Phase 2Updated Jul 27, 2026
Sponsor: University of Oklahoma
Rheumatoid Arthritis · Inflammation · Obesity
United States
Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)Completed
NCT06706999NAUpdated Jul 27, 2026
Sponsor: University of North Carolina, Chapel Hill
Rheumatoid Arthritis (RA) · Arthritis, Rheumatoid (RA)
United States
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid ArthritisRecruiting
NCT07620392Phase 2Updated Jul 24, 2026
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
United States, Poland
A Randomized Clinical Trial Evaluating the Efficacy of Clinical Pharmacist Assistance Along With Pharmaceutical and Non-pharmaceutical Therapy in the Early Rheumatoid ArthritisCompleted
NCT07726355Phase 2, Phase 3Updated Jul 24, 2026
Sponsor: Deraya University
Early Rheumatoid Arthritis
Egypt
The Pathogenesis and Natural History of Sjogren's DiseaseRecruiting
NCT01425892N/AUpdated Jul 23, 2026
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Sjogren's Syndrome · Salivary Gland · Pathogenesis
United States
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.Recruiting
NCT06916806Phase 1Updated Jul 23, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
United States, Canada, China, France, Germany +5 more
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesRecruiting
NCT06570798Phase 2Updated Jul 23, 2026
Sponsor: Amgen
Systemic Lupus Erythematosus · Active Refractory Rheumatoid Arthritis
United States, Australia, Belgium, France, Germany +5 more
Korean Post-marketing Surveillance for Xeljanz XRRecruiting
NCT04876781N/AUpdated Jul 23, 2026
Sponsor: Pfizer
Active Moderate to Severe Rheumatoid Arthritis · Active Ankylosing Spondylitis · Active Psoriatic Arthritis
South Korea
A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic DiseasesRecruiting
NCT07712939Phase 1Updated Jul 22, 2026
Sponsor: Candid Therapeutics
Healthy Participants Study · Rheumatoid Arthritis · Sjogren's Syndrome
Australia
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid ArthritisNot Yet Recruiting
NCT06016517N/AUpdated Jul 22, 2026
Sponsor: Tufts Medical Center
Arthritis, Rheumatoid
United States
Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid ArthritisRecruiting
NCT07721142Phase 4Updated Jul 22, 2026
Sponsor: Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Rheumatoid Arthritis (RA)
China
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren DiseaseRecruiting
NCT07281456Phase 2Updated Jul 21, 2026
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Sjogren's Syndrome
United States
Creating Health Course Study for People With Rheumatological Conditions and Mood DisordersRecruiting
NCT07180537NAUpdated Jul 21, 2026
Sponsor: Terry L. Wahls
Rheumatoid Arthritis · Sjogren's Syndrome · Systemic Lupus Erythematosus · Mixed Connective Tissue Disease
United States
Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid ArthritisRecruiting
NCT07484243N/AUpdated Jul 21, 2026
Sponsor: Dongyi He
Rheumatoid Arthritis (RA) · Rheumatoid Arthritis-Associated Interstitial Lung Disease · Difficult-to-Treat Rheumatoid Arthritis
China
The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid ArthritisCompleted
NCT03631225N/AUpdated Jul 21, 2026
Sponsor: Sequenom, Inc.
Rheumatoid Arthritis (RA)
United States
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARDActive Not Recruiting
NCT05936970N/AUpdated Jul 21, 2026
Sponsor: Aqtual, Inc.
Rheumatoid Arthritis
United States
Dysphagia in Rheumatoid ArthritisRecruiting
NCT07401732N/AUpdated Jul 21, 2026
Sponsor: Tanta University
Rheumatoid Arthritis (RA
Egypt
CD40L Antagonism in Rheumatoid Arthritis (RA)Terminated
NCT05306353Phase 2Updated Jul 20, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Rheumatoid Arthritis
United States
Umbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid Arthritis: A Randomized Double-Blind Placebo-Controlled TrialCompleted
NCT07715045Phase 2Updated Jul 20, 2026
Sponsor: Universitas Sriwijaya
Rheumatoid Arthritis
Indonesia
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RARecruiting
NCT07237659Phase 1Updated Jul 20, 2026
Sponsor: Neutrolis
SLE (Systemic Lupus) · RA - Rheumatoid Arthritis
United States
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)Recruiting
NCT07363590Phase 1Updated Jul 20, 2026
Sponsor: Merck Sharp & Dohme LLC
Systemic Lupus Erythematosus · Rheumatoid Arthritis
Australia, Belgium, China, Colombia, Georgia +5 more
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruiting
NCT07087912Phase 4Updated Jul 20, 2026
Sponsor: University of Sao Paulo General Hospital
Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE) · Juvenile Systemic Lupus Erythematosus
Brazil
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid ArthritisRecruiting
NCT07171983Phase 1Updated Jul 20, 2026
Sponsor: Bristol-Myers Squibb
Rheumatoid Arthritis
India

3,739 studies found